A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Themis Bioscience
MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience
The US-based big pharma MSD has entered the race to be the first to develop…
28/05/2020 - 3 minutes
Themis and Institut Pasteur Join Coronavirus Vaccine Hunt
The Austrian biotech Themis -- specializing in vaccines for infectious and insect-borne diseases -- has…
20/03/2020 - 3 minutes
Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase…
18/09/2019 - 3 minutes
Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’
Vienna-based Themis Bioscience will develop vaccine candidates against an undisclosed disease target in partnership with…
22/08/2019 - 2 minutes
Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine
The market is in sight for the first potential vaccine for the chikungunya virus, as…
04/06/2019 - 2 minutes
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
06/05/2019 - 6 minutes
First Potential Vaccine for Chikungunya Virus Flies Through Phase II
The mosquito-borne chikungunya virus may one day have a vaccine, as an Austrian biotech’s lead…
06/11/2018 - 2 minutes
UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine
UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards…
05/09/2017 - 3 minutes
Trouble in Paradise: How Biotech is Fighting Tropical Diseases
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech…
25/07/2017 - 6 minutes
Grüßgott, get to Meet 9 exciting Biotechs from Vienna
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The…
12/09/2016 - 6 minutes
Vienna-based Themis Bioscience frontlines vaccine development against emerging diseases
From Switzerland, we depart once again, this time for Vienna. This week, we are visiting…
02/09/2016 - 1 minute
